Objective and Subjective Assessment of the Effect of Levetiracetam on Daytime Sleepiness in Patients with Epilepsy

被引：0

作者：

Chaneva O. ^{[1
]}

Viteva E. ^{[2
,4
]}

Yaneva A. ^{[3
]}

机构：

[1] Department of Anesthesiology, Emergency and Intensive Care Medicine, University Hospital “Sveti Georgi”, Plovdiv

[2] Department of Neurology, Medical Faculty, Medical University, Plovdiv

[3] Department of Medical Informatics, Biostatistics and e-Learning, Faculty of Public Health, Medical University of Plovdiv, Plovdiv

[4] Clinic of Neurology, UMHAT “St. George”, 66, “Peshtersko Shosse” Blvd., Plovdiv

来源：

Sleep and Vigilance | 2023年 / 7卷 / 1期

关键词：

Daytime sleepiness; Epilepsy; Epworth sleepiness scale; Levetiracetam; Multiple sleep latency test;

D O I：

10.1007/s41782-023-00235-6

中图分类号：

学科分类号：

摘要：

Background: Levetiracetam (LEV) is a newer generation antiepileptic drug with unique anticonvulsive mechanism of action. It has been reported to cause daytime sleepiness in 4–15% of patients with epilepsy. Methods: We studied the effect of 2000 mg LEV monotherapy on daytime sleepiness over a 3-month period in patients with epilepsy. The subjective assessment of daytime sleepiness was made through Epworth sleepiness scale (ESS), and the objective assessment—through four naps MSLT. Both procedures were performed at baseline and after a 3-month period of LEV treatment. The dynamics in ESS score was measured as a shift from normal to excessive daytime sleepiness or vice versa. We studied two MSLT variables—mean sleep latency for all four naps and sleep stage. The dynamics in the mean sleep latency from baseline to the end of the third month of LEV treatment was also measured. Results: Twenty five patients participated in our study. The subjective and objective assessment of daytime sleepiness matched in only five of them. In none of the patients, ESS score was worsened after therapy. There was no statistically significant difference between the subjective assessment at baseline and after therapy (p = 0.250). There was no statistically significant difference between the objective assessment of daytime sleepiness at baseline and after therapy (r = 0.13). The patients with prolonged mean sleep latency reached a deeper sleep stage after therapy. The daytime sleepiness assessment correlated only with seizure frequency—patients with > 1 seizure a year had less variation in the degree of daytime sleepiness, i.e. more constant mean sleep latency. Conclusion: LEV 2000 mg/day does not worsen the subjective and the objective assessment of daytime sleepiness in patients with newly diagnosed or untreated epilepsy. © 2023, The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.

引用

页码：97 / 103

页数：6

共 18 条

[1]

Lynch B.A., Lambeng N., Nocka K., Et al., The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam, Proc Natl Acad Sci USA, 101, pp. 9861-9866, (2004)

[2]

Bazil C.W., Sleep and epilepsy, Semin Neurol, 22, pp. 321-327, (2002)

[3]

Mendez M., Radke R.A., Interactions between sleep and epilepsy, J Clin Neurophysiol, 18, pp. 106-127, (2001)

[4]

De Weerd A., de Haas S., Otte A., Kasteleijn-Nolst Trenite D., van Erp G., Cohen A., de Kam M., van Gerven J., Subjective sleep disturbance in patient with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life, Epilepsia, 45, pp. 1397-1404, (2004)

[5]

Ayala-Guerrero F., Mexicano G., Gonzalez V., Et al., Effect of oxcarbazepine on sleep architecture, Epilepsy Behav, 15, pp. 287-289, (2009)

[6]

Marzec M., Edwards J., Sagher O., Fromes G., Malow B.A., Effects of vagus nerve stimulation on sleep-related breathing in epilepsy patients, Epilepsia, 44, pp. 930-935, (2003)

[7]

Sadek A., French J.A., Et al., Levetiracetam, The treatment of epilepsy, (2004)

[8]

Placidi F., Scalise A., Marciani M.G., Et al., Effect of antiepileptic drugs on sleep, Clin Neurophysiol, 111, pp. 115-119, (2000)

[9]

Legros B., Bazil C.W., Effects of antiepileptic drugs on sleep architecture: a pilot study, Sleep Med, 4, pp. 51-55, (2003)

[10]

Cho Y.W., Kim D.H., Motamedi G.K., The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy, Seizure, 20, pp. 336-339, (2011)

← 1 2 →